Skip to content
OpenCapital
Get started

Pulmonx Corporation LUNG Q4 2025 Annual earnings

Reported March 4, 2026 · After market close

Revenue$22.6MBeat by $869.7K
EPS-$0.25Beat by $0.14
Revenue estimate$21.7M
EPS estimate-$0.39

Next report

Date not yet announced

Financials

Q4 2025

Income statement

See full
Revenue$22.6M-4.9%
Gross profit$17.5M-0.3%
Operating income-$9.9M+26.2%
Net income-$10.4M+20.9%
EPS (diluted)-$0.25+24.2%

Balance sheet

See full
Cash & equivalents$68.7M+6.9%
Total debt$56.4M-0.2%
Total equity$54.1M-36.9%
Total assets$129.3M-20.6%

Cash flow

See full
Operating cash flow-$7.1M-5.3%
CapEx$13.0K-88.3%
Free cash flow-$7.1M-3.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$91.16M-66.0%
Enterprise value$78.81M-69.7%
P/S1×-2.2×

Profitability

See full
Gross margin74.2%+0.2pp
Operating margin-59.3%-7.2pp
Net margin-59.7%-6.1pp
FCF margin-36.3%-2.6pp

Returns & leverage

See full
Return on equity-77.2%+50.8pp
Debt / equity1×+0.4×
Current ratio5.1×-0.5×

Segments

By geography

See full
Europe, Middle-East and Africa (“EMEA”)$7.9M+28.6%
Asia Pacific$565.0K-66.0%
Other International$52.0K-48.5%

Versus estimates

Revenue

Q1 2026$20.6MBeat by $154.6K
Q4 2025$22.6MBeat by $869.7K
Q3 2025$21.5MMiss by $226.3KQ2 2025$23.9MBeat by $466.2KQ1 2025$22.5MBeat by $505.1KQ4 2024$23.8MBeat by $1.5M

Diluted EPS

Q1 2026-$0.33In line
Q4 2025-$0.25Beat by $0.14
Q3 2025-$0.34Beat by $0.06Q2 2025-$0.38Beat by $0.02Q1 2025-$0.36Beat by $0.01Q4 2024-$0.33Beat by $0.12

Ask the moment Pulmonx Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Pulmonx Corporation report Q4 2025 earnings?
Pulmonx Corporation (LUNG) reported Q4 2025 earnings on March 4, 2026 after market close.
What were Pulmonx Corporation's Q4 2025 revenue and EPS?
Pulmonx Corporation reported revenue of $22.6M and eps of $-0.25 for Q4 2025.
Did Pulmonx Corporation beat estimates in Q4 2025?
Revenue beat the consensus estimate of $21.7M by $869.7K. EPS beat the consensus estimate of $-0.39 by $0.14.
How did Pulmonx Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.9% from $23.8M a year earlier and eps grew 24.2% from $-0.33.
Where can I find Pulmonx Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001127537-26-000003) and the 10-K periodic report (0001127537-26-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.